TMO

$682.652.06%-14.35

Nachbörslich: 684.13+1.48 +0.22%

Thermo Fisher Scientific Inc (TMO)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$697.00

Offen:

$699.86

24-Stunden-Volumen:

1,522,980

Relatives Volumen:

0.63

Marktkapitalisierung:

$252.41B

Einnahmen:

$45.20B

Nettoeinkommen (Verlust:

$6.87B

KGV:

37.53

EPS:

$18.19

Netto-Cashflow:

$6.75B

1W Leistung:

-0.33%

1M Leistung:

+4.25%

6M Leistung:

+45.49%

1Y Leistung:

+20.31%

1-Tages-Spanne:

$679.40$699.86

1-Wochen-Bereich:

$679.40$711.85

52-Wochen-Spanne:

$435.27$711.85

Thermo Fisher Scientific Inc Aktie (TMO) Unternehmensprofil

Firmenname

Thermo Fisher Scientific Inc

Sektor

Healthcare

Branche

Diagnostics & Research

Telefon

(781) 622-1000

Adresse

168 THIRD AVENUE, WALTHAM, MA, USA

Mitarbeiter

125,000

@thermofisher

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

TMO-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Thermo Fisher Scientific Inc Aktie (TMO) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-09	Hochstufung	UBS	Neutral → Buy
2026-09-03	Eingeleitet	CLSA	Outperform
2026-06-26	Resumed	Bernstein	Mkt Perform
2026-06-11	Eingeleitet	Piper Sandler	Neutral
2026-06-03	Herabstufung	HSBC Securities	Buy → Hold
2026-06-02	Resumed	Wolfe Research	Outperform
2026-05-15	Resumed	RBC Capital Mkts	Sector Perform
2026-03-27	Eingeleitet	DZ Bank	Buy
2025-12-11	Hochstufung	Citigroup	Neutral → Buy
2025-12-09	Eingeleitet	Goldman	Buy
2025-12-08	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2025-12-02	Resumed	Morgan Stanley	Overweight
2025-12-01	Hochstufung	HSBC Securities	Hold → Buy
2025-09-11	Hochstufung	Barclays	Equal Weight → Overweight
2025-08-19	Eingeleitet	William Blair	Outperform
2025-07-24	Herabstufung	HSBC Securities	Buy → Hold
2025-07-11	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	Herabstufung	UBS	Buy → Neutral
2025-01-10	Hochstufung	Bernstein	Mkt Perform → Outperform
2024-12-23	Eingeleitet	Scotiabank	Sector Perform
2024-10-14	Eingeleitet	Redburn Atlantic	Buy
2024-10-01	Eingeleitet	Stephens	Overweight
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-03	Resumed	Jefferies	Buy
2024-03-18	Resumed	Citigroup	Neutral
2024-01-24	Herabstufung	Barclays	Overweight → Equal Weight
2024-01-08	Herabstufung	Bernstein	Outperform → Mkt Perform
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-10-26	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	Hochstufung	Wells Fargo	Underweight → Equal Weight
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-09-06	Resumed	Citigroup	Buy
2023-07-19	Eingeleitet	Raymond James	Outperform
2023-07-19	Bestätigt	Robert W. Baird	Outperform
2023-07-13	Hochstufung	Credit Suisse	Neutral → Outperform
2023-04-04	Bestätigt	Barclays	Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2022-08-25	Eingeleitet	Credit Suisse	Neutral
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-01-26	Resumed	Barclays	Overweight
2021-10-20	Hochstufung	Citigroup	Neutral → Buy
2021-10-15	Resumed	Cowen	Outperform
2021-08-05	Resumed	Credit Suisse	Outperform
2021-07-16	Eingeleitet	The Benchmark Company	Buy
2021-03-18	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Eingeleitet	Barclays	Overweight
2021-01-08	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-12-02	Eingeleitet	Goldman	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-09-14	Eingeleitet	Morgan Stanley	Overweight
2020-08-20	Resumed	JP Morgan	Overweight
2020-07-15	Hochstufung	Cleveland Research	Neutral → Buy
2020-07-07	Bestätigt	Needham	Buy
2020-04-23	Bestätigt	Needham	Buy
2020-01-31	Bestätigt	Needham	Buy
2020-01-22	Eingeleitet	Credit Suisse	Neutral
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Buy
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-25	Bestätigt	Needham	Buy
2019-07-16	Herabstufung	Needham	Strong Buy → Buy
2019-05-30	Eingeleitet	Wolfe Research	Outperform
2019-05-23	Bestätigt	Needham	Strong Buy
2019-04-22	Bestätigt	Needham	Strong Buy
2019-04-16	Bestätigt	BofA/Merrill	Buy

Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	44,556.00	42,879.00	42,857.00	44,915.00	39,211.00
Research and development USD (M)	1,397.00	1,390.00	1,337.00	1,471.00	1,406.00
Operating expenses USD (M)	36,810.00	35,542.00	35,998.00	36,522.00	29,183.00
Operating income USD (M)	7,746.00	7,337.00	6,859.00	8,393.00	10,028.00
Income before tax USD (M)	7,308.00	7,037.00	6,298.00	7,835.00	8,841.00
Income tax expense USD (M)	547.00	657.00	284.00	703.00	1,109.00
Net income USD (M)	6,721.00	6,338.00	5,955.00	6,960.00	7,728.00
Basic EPS USD/shares	17.77	16.58	15.52	17.75	19.62
Diluted EPS USD/shares	17.74	16.53	15.45	17.63	19.46
Basic weighted shares shares (M)	377.00	382.00	386.00	392.00	394.00
Diluted weighted shares shares (M)	378.00	383.00	388.00	394.00	397.00
Selling, general and administrative USD (M)	8,732.00	8,595.00	8,445.00	8,993.00	8,007.00

Thermo Fisher Scientific Inc-Aktie (TMO) Insiderhandel

Britt Lisa P.Oct 28 '26
Officer
Transaktion
Proposed Sale
Kosten
$706.45
#Aktien
2,831
Wert ($)
1,999,960
#Aktien Gesamt
0
Britt Lisa P.Oct 28 '26
Sr. VP and Chief HR Officer
Transaktion
Sale
Kosten
$706.45
#Aktien
2,831
Wert ($)
1,999,960
#Aktien Gesamt
11,560
Pettiti GianlucaAug 31 '26
President & COO
Transaktion
Sale
Kosten
$614.38
#Aktien
4,133
Wert ($)
2,539,233
#Aktien Gesamt
23,216
Pettiti GianlucaAug 31 '26
Officer
Transaktion
Proposed Sale
Kosten
$614.38
#Aktien
4,133
Wert ($)
2,539,233
#Aktien Gesamt
0
Pettiti GianlucaAug 31 '26
President & COO
Transaktion
Option Exercise
Kosten
$309.63
#Aktien
3,733
Wert ($)
1,155,849
#Aktien Gesamt
26,949
CASPER MARC NAug 24 '26
Chairman & CEO
Transaktion
Sale
Kosten
$627.05
#Aktien
275
Wert ($)
172,439
#Aktien Gesamt
123,925
CASPER MARC NAug 24 '26
Officer
Transaktion
Proposed Sale
Kosten
$627.05
#Aktien
275
Wert ($)
172,438
#Aktien Gesamt
0
CASPER MARC NAug 24 '26
Chairman & CEO
Transaktion
Option Exercise
Kosten
$309.63
#Aktien
275
Wert ($)
85,148
#Aktien Gesamt
124,200
CASPER MARC NAug 21 '26
Officer
Transaktion
Proposed Sale
Kosten
$626.91
#Aktien
10,000
Wert ($)
6,269,123
#Aktien Gesamt
0
CASPER MARC NAug 21 '26
Chairman & CEO
Transaktion
Sale
Kosten
$626.92
#Aktien
10,000
Wert ($)
6,269,153
#Aktien Gesamt
123,925

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Britt Lisa P.	Officer	Oct 28 '26	Proposed Sale	$706.45	2,831	1,999,960	0
Britt Lisa P.	Sr. VP and Chief HR Officer	Oct 28 '26	Sale	$706.45	2,831	1,999,960	11,560
Pettiti Gianluca	President & COO	Aug 31 '26	Sale	$614.38	4,133	2,539,233	23,216
Pettiti Gianluca	Officer	Aug 31 '26	Proposed Sale	$614.38	4,133	2,539,233	0
Pettiti Gianluca	President & COO	Aug 31 '26	Option Exercise	$309.63	3,733	1,155,849	26,949
CASPER MARC N	Chairman & CEO	Aug 24 '26	Sale	$627.05	275	172,439	123,925
CASPER MARC N	Officer	Aug 24 '26	Proposed Sale	$627.05	275	172,438	0
CASPER MARC N	Chairman & CEO	Aug 24 '26	Option Exercise	$309.63	275	85,148	124,200
CASPER MARC N	Officer	Aug 21 '26	Proposed Sale	$626.91	10,000	6,269,123	0
CASPER MARC N	Chairman & CEO	Aug 21 '26	Sale	$626.92	10,000	6,269,153	123,925

Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten

Nov 02, 2026

Beat the Market Like Zacks: Marathon Petroleum, Amgen, Chevron in Focus - Zacks Investment Research

Nov 02, 2026

Oct 30, 2026

RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs - Zacks Investment Research

Oct 30, 2026

Oct 28, 2026

Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast - 2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million Opportunity - GlobeNewswire Inc.

Oct 28, 2026

Oct 27, 2026

15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge - GlobeNewswire Inc.

Oct 27, 2026

Top Research Reports for Alphabet, ExxonMobil & Toyota Motor - Zacks Investment Research

Oct 27, 2026

Oct 26, 2026

Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch

Oct 26, 2026

Oct 25, 2026